Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins as immunomodulators.

François Mach1

  • 1Department of Medicine, University Hospital Geneva, Foundation for Medical Research, Switzerland. machf@cmu.unige.ch

Transplant Immunology
|August 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Weight change and long-term cardiovascular outcomes in overweight and obese patients after acute coronary syndromes.

European heart journal open·2026
Same author

Safety of low lipoprotein(a) levels: the FOURIER trial.

European heart journal·2026
Same author

Revue medicale suisse·2026
Same author

[Chronic coronary syndrome : advanced cardiac imaging].

Revue medicale suisse·2026
Same author

[Chagas cardiomyopathy].

Revue medicale suisse·2026
Same author

Erratum to "2025 Focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias" [Atherosclerosis, 409, (October 2025), 120479].

Atherosclerosis·2026
Same journal

Clinical outcomes of myeloablative allogeneic peripheral blood stem cell transplantation for relapsed/refractory T-ALL/LBL: A single-center study.

Transplant immunology·2026
Same journal

Retrospective study on allogeneic hematopoietic stem cell transplantation for the treatment of Hemophagocytic lymphohistiocytosis.

Transplant immunology·2026
Same journal

HLA selected red cell transfusions to prevent HLA sensitisation: a prospective, double-blinded, randomised controlled trial.

Transplant immunology·2026
Same journal

Efficacy and safety of nilotinib in steroid-refractory chronic graft-versus-host disease: A systematic review and meta-analysis.

Transplant immunology·2026
Same journal

Evaluation of the bioassay for detecting early endothelial activation using microvascular cultures in renal transplant recipients.

Transplant immunology·2026
Same journal

Diagnostic performance of EUS-FNA for pancreatic lesions at tertiary centers in Iran without rapid on-site evaluation.

Transplant immunology·2026
See all related articles

Statins, commonly used to lower cholesterol, were found to inhibit the immune response by blocking major histocompatibility complex class II (MHC-II) expression. This discovery reveals statins as novel immunomodulators with potential applications beyond cardiovascular health.

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • HMG-CoA reductase inhibitors (statins) are widely used lipid-lowering drugs.
  • Statins' role in immune response was previously unestablished, despite some clinical observations suggesting benefits in organ transplantation.
  • Major histocompatibility complex class II (MHC-II) molecules are crucial for T lymphocyte activation and immune response control.

Purpose of the Study:

  • To investigate the potential immunomodulatory effects of statins.
  • To determine if statins influence the expression of MHC-II molecules.
  • To explore the implications of statins' effects on T cell activation.

Main Methods:

  • Investigated the effect of statins on the induction of MHC-II expression by interferon gamma (IFN-gamma).

Related Experiment Videos

  • Utilized primary human endothelial cells and macrophages for experimental models.
  • Examined the specificity of statin effects on inducible MHC-II versus constitutive MHC-II and MHC-I expression.

    • Main Results:

    • Statins were demonstrated to be direct inhibitors of IFN-gamma-induced MHC-II expression.
    • This inhibitory effect was observed in multiple cell types, including endothelial cells and macrophages.
    • The inhibition was specific to inducible MHC-II expression, not affecting constitutive MHC-II or MHC-I expression.

    Conclusions:

    • Statins act as novel immunomodulators by repressing the induction of MHC-II.
    • This mechanism provides a scientific basis for statins' potential use as immunosuppressors.
    • Statins may be beneficial in organ transplantation and other immune-related pathologies.